Altrova Health Inc.
ROVA
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 80.50K | -- | 10.10K | 11.20K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 80.50K | -- | 10.10K | 11.20K | -- |
| Cost of Revenue | 35.50K | -- | 30.10K | 4.20K | -- |
| Gross Profit | 45.10K | -- | -20.00K | 7.00K | -- |
| SG&A Expenses | 559.10K | 235.50K | 288.40K | 269.20K | 322.30K |
| Depreciation & Amortization | 20.70K | -- | -1.70K | 500.00 | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 615.30K | 235.50K | 316.80K | 274.00K | 322.30K |
| Operating Income | -534.70K | -235.50K | -306.70K | -262.70K | -322.30K |
| Income Before Tax | -561.50K | -247.70K | -2.31M | -276.90K | -363.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -561.50K | -247.70K | -2.31M | -276.90K | -363.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -561.50K | -247.70K | -2.31M | -276.90K | -363.40K |
| EBIT | -534.70K | -235.50K | -306.70K | -262.70K | -322.30K |
| EBITDA | -523.10K | -225.80K | -306.20K | -262.20K | -321.70K |
| EPS Basic | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 201.08M | 186.85M | 171.70M | 175.88M | 124.11M |
| Average Diluted Shares Outstanding | 201.08M | 186.85M | 171.70M | 175.88M | 124.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |